Contact Us
Subscribe
E-Edition

36°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
Sports
Obits
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Subscribe
Archives
Best of 2025
Pet Contest

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Alcon Inc. Ordinary Shares (NY:ALC)

79.08 +0.88 (+1.13%)

Streaming Delayed Price Updated: 12:36 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

American Eagle, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday ↗

May 14, 2025

Via Benzinga

Alcon Earnings Preview ↗

May 12, 2025

Via Benzinga

3 Stocks Upping Dividends & 1 With A 10% Special Dividend Yield

April 16, 2025

Via MarketBeat

Alcon Eyes Surgical Edge With LENSAR Buyout: Details ↗

March 24, 2025

Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser technologies, boosting Alcon's offerings in femtosecond laser-assisted cataract...

Via Benzinga

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

Apple To $253? Here Are 10 Top Analyst Forecasts For Friday ↗

January 24, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Alcon Analysts Increase Their Forecasts After Q2 Results ↗

August 22, 2024

Via Benzinga

Alcon Analysts Increase Their Forecasts Following Q1 Results ↗

May 15, 2024

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

December 17, 2024

Via Benzinga

Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday ↗

September 12, 2024

Via Benzinga

ALC Stock Earnings: Alcon Beats EPS, Misses Revenue for Q2 2024 ↗

August 20, 2024

ALC stock results show that Alcon beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone ↗

August 20, 2024

Via Benzinga

Topics Stocks

Lowe's, Palo Alto Networks And 3 Stocks To Watch Heading Into Tuesday ↗

August 20, 2024

Via Benzinga

Week In Review: Eisai Enters $1.5 Billion Molecular Glues Pact With SEED ↗

August 17, 2024

Japan’s Eisai Pharma formed a collaboration with SEED, a Pennsylvania biotech, to develop molecular glues for targeted protein degradation of disease-causing proteins. SEED is eligible to receive up to...

Via Talk Markets

US Stocks Trim Gains As Iran Mulls Attack On Israel; Gold, Oil Rally: What's Driving Markets Monday? ↗

August 12, 2024

Wall Street turns negative due to geopolitical risks. Gold rises 1.5% and stocks edge higher. Scotiabank acquires minority stake in KeyCorp.

Via Benzinga

Nasdaq, S&P 500 Futures Climb After Volatile Week As Traders Eye Inflation Data and Retail Earnings: Strategist Says Not CPI But This Data Can Give People Lot Of Conviction ↗

August 12, 2024

The resilience of the market was in full display on Monday after last week’s “historical comeback” by the market. The major index futures traded higher, albeit by a modest magnitude.

Via Benzinga

Topics Economy Stocks

Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock? ↗

July 16, 2024

Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2?

Via Benzinga

ALC Stock Earnings: Alcon Beats EPS, Misses Revenue for Q1 2024 ↗

May 20, 2024

ALC stock results show that Alcon beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Do You Have Your Eye On Vision Care Stocks? ↗

May 20, 2024

For investors seeking stable and growing opportunities, eye care stocks are an attractive option.

Via Talk Markets

MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio? ↗

May 19, 2024

Top performing large-cap stocks in the last week: MSTR, MNDY, ONON, SE, PODD, DELL, VOD, ALC, SMCI, CRBG. Analysts raise price targets & more positive news.

Via Benzinga

Contact Lens Maker Alcon's Has New Growth Avenues, Analyst Upgrades Stock ↗

May 15, 2024

Alcon's recent upgrades and promising opportunities, including the BELKIN Vision acquisition, expanding glaucoma treatment options, enhanced PanOptix IOL, and market advancements in China.

Via Benzinga

Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 14, 2024

Via Benzinga

Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday ↗

May 14, 2024

Via Benzinga

Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

May 14, 2024

Via Benzinga

2 Intriguing Medical Stocks To Buy For Steady Growth As Earnings Approach ↗

May 14, 2024

Among the medical sector, Alcon and Prestige Consumer Healthcare are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.

Via Talk Markets

Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month ↗

February 09, 2024

"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins...

Via Benzinga

Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: 'Innovation Is Key' ↗

January 23, 2024

Innovation and digitalization have been in focus among ophthalmology majors.

Via Benzinga

Good News For Dry Eye Disease Patients: Eye Care Focused Alcon's Treatment Shows Encouraging Benefit In Late-Stage Trials ↗

January 10, 2024

Alcon (NYSE: ALC) released topline results from the two Phase 3 trials (COMET-2 and COMET-3) evaluating the efficacy and safety of AR-15512, a candidate treatment for the signs and symptoms of

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

starkvilledailynews.com
304 E. Lampkin Street,
Starkville, MS 39759
Phone: 662-323-1642
Email: editor@starkvilledailynews.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Alcon Inc. Ordinary Shares (NY:ALC)

Headline News about Alcon Inc. Ordinary Shares

Sections

Services

Follow Us